Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects

NCT03311659 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

448

Enrollment

INDUSTRY

Sponsor class

Conditions

Diphtheria-Tetanus-acellular Pertussis Vaccines

Interventions

BIOLOGICAL: Boostrix

Sponsor

GlaxoSmithKline